CEimpact Podcast

In an era where informed decisions are crucial to public health, understanding vaccine hesitancy has never been more critical.

Listen in to this week’s GC episode to learn actionable steps you can make today to break down vaccine hesitancy barriers and provide an accurate and data-driven approach to vaccine education in your community.

HOST
Jen Moulton, BSPharm
President
CEimpact

GUEST
Lacy Epperson, PharmD
Director of Pharmacy Clinical Services
Mitchell's Drug Stores
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Analyze the underlying factors contributing to vaccine hesitancy and their effects on public health.
2. Discuss effective communication and outreach strategies to increase vaccination rates within a pharmacys community.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-262-H06-P
Initial release date: 9/23/2024
Expiration date: 9/23/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

According to the National Heart, Lung, and Blood Institute (NHLBI), 50–70 million Americans have sleep disorders, and one in three adults don't get enough uninterrupted sleep to maintain their health. 

Listen in to this week’s GC episode to learn the physiology of sleep, why we need sleep, and what our role is in educating patients on sleep hygiene sleep disorders, and OTC vs. Non-OTC options. 

HOST
Jen Moulton, BSPharm
President
CEimpact

GUEST
Ezequiel Medina, PharmD
Sleep Coach and Pharmacist
Live Love Sleep

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common sleep disorders and their impact on patient health and outcomes.
2. Explain strategies for managing sleep disorders through pharmacological and non-pharmacological interventions in pharmacy practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-263-H01-P
Initial release date: 9/16/2024
Expiration date: 9/16/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

A Community Health Worker (CHW) is a frontline public health worker who is a trusted member of the community they serve. CHWs act as a bridge between health and social services and the community, helping to improve health outcomes and access to care.

Our goal during this episode is to discuss why training pharmacy technicians to step into the role of a Community Health Worker has been imperative to meeting the health equity demands in local communities.
 
Jen Moulton, BSPharm
President
CEimpact

Meredith Ayers, CPhT-Adv, CHW
Development Specialist
Bremo Pharmacy

This course is accredited for Pharmacists & Pharmacy Technicians:
Pharmacist Members, REDEEM YOUR CPE HERE!

Pharmacist Technicians, REDEEM YOUR CPE HERE!
When the course page populates, click Enroll and complete the system prompts to add the course to your My Courses. 

 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the role and impact of pharmacy-placed Community Health Workers (CHWs) on patient outcomes and community health.
2. Describe a plan to integrate CHWs into pharmacy practice by cross-training pharmacy technicians.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-289-H04-P and 0107-0000-25-289-H04-T
Initial release date: 9/10/2025
Expiration date: 9/10/2028
Additional CPE details can be found here for pharmacists and here for pharmacy technicians.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Drug resistance to antibiotics continues to escalate. This week we do a deep dive into the Infectious Disease Society of America's (IDSA) brand new guidance on the treatment of antimicrobial resistant gram-negative infections.
 
The GameChanger
The new IDSA guidelines provide critical, evidence-based recommendations for managing drug-resistant gram-negative infections. The guidance offers health care providers clear strategies to improve outcomes and reduce the emergence of resistance.


Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Amanda Bushman, PharmD, BCPS-AQ ID, BCIDP, FIDSA
Infectious Disease Pharmacist
UnityPoint Health

Tony Mannum, PharmD
PGY2 Infectious Disease Resident
UnityPoint Health
Reference

IDSA Guidelines for treating resistant gram negative organisms

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify effective strategies for treating urinary tract and systemic infections caused by Extended-Spectrum Beta-Lactamase (ESBL)-producing organisms.
2. Discuss appropriate therapeutic agents for infections caused by AmpC beta-lactamase-producing bacteria, ensuring choices minimize the risk of resistance development during treatment.

0.05 CEU/0.5 Hr
UAN:  0107-0000-24-251-H01-P
Initial release date: 09/02/2024
Expiration date: 09/02/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The Society of Critical Care Medicine just released their first set of updated stress ulcer prophylaxis (SUP) guidelines since 1999 that include groundbreaking changes. We also discuss evidence on proton pump inhibitor (PPI) use for SUP that impacts ICU practice.
 
The GameChanger
New guidelines for use of PPIs for stress ulcer prophylaxis will have a significant impact on ICU practice.
 
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Matthew Trump, DO, FACP, FCCP
Pulmonologist
The Iowa Clinic
 
Reference
Guidelines
Paper

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the new Stress Ulcer Prophylaxis (SUP) guidelines from the Society of Critical Care Medicine (SCCM), including identifying patients at risk.
2. Discuss the use of Proton Pump Inhibitors (PPI) and Histamine-2 Receptor Antagonists (H2RA) for Stress Ulcer Prophylaxis (SUP).

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-247-H01-P
Initial release date: 08/26/2024
Expiration date: 08/26/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Stigmatizing language may be part of our daily interactions with patients without even realizing it. It can appear in charts, regardless of race, gender, gender identity, ability, or socioeconomic status, but it has been found to occur more frequently for groups who are traditionally marginalized. How often do you reflect on the language you use with patients and how it might be interpreted by them, depending on their unique circumstances? And what are we doing as preceptors to help our residents and students understand the importance of language in their patient interactions? Listen in to learn more.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Kashelle Lockman, PharmD, MA
Clinical Associate Professor
University of Iowa

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. List examples of stigmatizing language and its impact on pharmacist-patient interactions
2. Describe strategies preceptors can use to foster the use of non-stigmatizing language by students and residents

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-250-H99-P
Initial release date: 8/21/2024
Expiration date: 8/21/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay it's onset.
 
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.
 
Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
The recombinant shingles vaccine is associated with lower risk of dementia

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

We delve into the implications of the recent study published in JAMA Internal Medicine, exposing how older risk models overestimate cardiovascular risk by about 50%. This overestimation has profound implications for primary statin use, insurer policies, and regulatory practices. Our discussion highlights the need for updated guidelines that reflect the most current evidence, ensuring better patient care and aligning clinical practice with the latest scientific findings.
 
The GameChanger
Adopting the PREVENT equations could significantly refine statin prescriptions, ensuring millions of adults receive appropriate cardiovascular risk management.
 
Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

Previous GameChangers on PREVENT score

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of the PREVENT equations on statin prescription recommendations for cardiovascular disease prevention.
2. Explain clinical implications and practice changes from integrating the PREVENT equations into cardiovascular risk guidelines.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-245-H01-P
Initial release date: 08/12/2024
Expiration date: 08/12/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The power of physical fitness in managing diabetes is transforming patient care. Join us this week as we discuss how pharmacists can significantly enhance patient outcomes by integrating exercise education into their practice, alongside traditional medication management.
 
The GameChanger
Incorporating brief but impactful conversations about the importance of physical fitness into patient consultations can significantly enhance diabetes management.
 
Guests
Mark Smith, Jr., PharmD, CDCES, AFAA-CGFI
Pharmacist
UAB Medicine

Ian Haywood, PharmD, BCPS, CDCES
Clinical Pharmacist
Baptist Memorial Hospital

 
Reference Materials
The Role of Exercise in Diabetes
Physical Activity and Diabetes Position from the ADA

Supplemental Continuing Education Courses
Glucose Whisperers: The Role of CGMs in Pharmacy Practice - 1hr
Guardians of the Glucose Galaxy: The Rise of CGMs - 1hr
Pharmacy and Continuous Glucose Monitoring: The Sweetest Pairing - 6.5hrs

Additional GameChangers Episodes
Continuous Glucose Monitors

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the impact of physical fitness on diabetes management.
2. Identify strategies for educating patients on exercise and diabetes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-224-H01-P
Initial release date: 08/05/2024
Expiration date: 08/05/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

GLP1 usage is on the rise. This week on GameChangers, we discuss the latest data on using GLP-1s for sleep apnea and weight loss.
 
The GameChanger
Several new studies suggest GLP-1 and GLP/GIP medications have positive clinical impact on sleep apnea and weight loss.

Guests
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad
 
References
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity


Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the use of GLP-1 medications in the treatment of obstructive sleep apnea.
2. Discuss the relative weight loss in a recent study between a GLP-1 and GLP/GIP drugs.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-238-H01-P
Initial release date: 07/29/2024
Expiration date: 07/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram